# Ralliant Corp: overview

RAL · NYSE · CIK 2041385 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ral.md) · [Financials](/companies/ral/financials.md) · [Filings](/companies/ral/filings.md) · [Insiders](/companies/ral/insiders.md)

Latest reported revenue: [$567.8m](/filings/0002041385-26-000065.md) for Q2 FY2026, three months to 2026-07-03, from the 10-Q filed Jul 30, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0002041385-26-000065).

## Last eight quarters

| Line item | Unit | period not labelled (2024-09-27) | period not labelled (2024-12-31) | period not labelled (2025-03-28) | Q2 FY2025 (2025-06-27) | Q3 FY2025 (2025-09-26) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-04-03) | Q2 FY2026 (2026-07-03) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [532](/filings/0002041385-25-000069.md) | [548 d](/filings/0002041385-26-000023.md) | [482](/filings/0002041385-26-000046.md) | [503](/filings/0002041385-26-000065.md) | [529](/filings/0002041385-25-000069.md) | [555 d](/filings/0002041385-26-000023.md) | [535](/filings/0002041385-26-000046.md) | [568](/filings/0002041385-26-000065.md) |
| Gross margin | % | [52.6%](/filings/0002041385-25-000069.md) | [51.4% d](/filings/0002041385-26-000023.md) | [50.5%](/filings/0002041385-26-000046.md) | [49.3%](/filings/0002041385-26-000065.md) | [50.8%](/filings/0002041385-25-000069.md) | [50.5% d](/filings/0002041385-26-000023.md) | [50.9%](/filings/0002041385-26-000046.md) | [51.6%](/filings/0002041385-26-000065.md) |
| Operating margin | % | [20.9%](/filings/0002041385-25-000069.md) | [18.6% d](/filings/0002041385-26-000023.md) | [15.3%](/filings/0002041385-26-000046.md) | [11.7%](/filings/0002041385-26-000065.md) | [9.8%](/filings/0002041385-25-000069.md) | [(246.7%) d](/filings/0002041385-26-000023.md) | [12.7%](/filings/0002041385-26-000046.md) | [14.5%](/filings/0002041385-26-000065.md) |
| Net margin | % | [17.1%](/filings/0002041385-25-000069.md) | [15.1% d](/filings/0002041385-26-000023.md) | [13.3%](/filings/0002041385-26-000065.md) | [9.5%](/filings/0002041385-26-000065.md) | [7.5%](/filings/0002041385-25-000069.md) | [(247.8%) d](/filings/0002041385-26-000023.md) | [8.3%](/filings/0002041385-26-000065.md) | [10.1%](/filings/0002041385-26-000065.md) |
| Diluted EPS | $ per share | [0.81](/filings/0002041385-25-000069.md) | not reported | [0.57](/filings/0002041385-26-000046.md) | [0.42](/filings/0002041385-26-000065.md) | [0.35](/filings/0002041385-25-000069.md) | not reported | [0.39](/filings/0002041385-26-000046.md) | [0.51](/filings/0002041385-26-000065.md) |
| Free cash flow | $m | [132 d](/filings/0002041385-25-000069.md) | [147 d](/filings/0002041385-26-000023.md) | [66.4](/filings/0002041385-26-000046.md) | [73.8 d](/filings/0002041385-26-000065.md) | [127 d](/filings/0002041385-25-000069.md) | [91.6 d](/filings/0002041385-26-000023.md) | [10.4](/filings/0002041385-26-000046.md) | [99.1 d](/filings/0002041385-26-000065.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY (2023-12-31) | FY (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: |
| Revenue | $m | [2,156](/filings/0002041385-26-000023.md) | [2,155](/filings/0002041385-26-000023.md) | [2,069](/filings/0002041385-26-000023.md) |
| Gross margin | % | [51.9%](/filings/0002041385-26-000023.md) | [51.6%](/filings/0002041385-26-000023.md) | [50.3%](/filings/0002041385-26-000023.md) |
| Operating margin | % | [23.7%](/filings/0002041385-26-000023.md) | [21.3%](/filings/0002041385-26-000023.md) | [(57.2%)](/filings/0002041385-26-000023.md) |
| Net margin | % | [19.3%](/filings/0002041385-26-000023.md) | [16.5%](/filings/0002041385-26-000023.md) | [(59.1%)](/filings/0002041385-26-000023.md) |
| Diluted EPS | $ per share | [3.70](/filings/0002041385-26-000023.md) | [3.15](/filings/0002041385-26-000023.md) | [(10.84)](/filings/0002041385-26-000023.md) |
| Free cash flow | $m | [433](/filings/0002041385-26-000023.md) | [420](/filings/0002041385-26-000023.md) | [358](/filings/0002041385-26-000023.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ral/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $1.04bn | 14,117,630 |  | Added +574,577 |
| [Dodge & Cox](/funds/200217.md) | 2026-06-30 | $1.03bn | 14,005,203 |  | Added +257,652 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $565.2m | 7,676,579 |  | Reduced −778,674 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $372.3m | 5,056,526 |  | Reduced −10,726 |
| [MILLENNIUM MANAGEMENT LLC](/funds/1273087.md) | 2026-06-30 | $331.7m | 4,504,829 |  | Added +143,152 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $281.4m | 3,822,557 |  | Added +143,713 |
| [FLOSSBACH VON STORCH SE](/funds/1575677.md) | 2026-06-30 | $222.5m | 3,021,324 |  | Reduced −685,561 |
| [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $174.2m | 2,365,461 |  | Added +777,864 |
| [FULLER & THALER ASSET MANAGEMENT, INC.](/funds/1082327.md) | 2026-06-30 | $166.1m | 2,255,379 |  | New +2,255,379 |
| [ARROWSTREET CAPITAL, LIMITED PARTNERSHIP](/funds/1164508.md) | 2026-06-30 | $142.7m | 1,937,397 |  | Added +473,619 |

## Recent filings

[All 156 filings](/companies/ral/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-07-30 | 20:18 ET | [10-Q](/filings/0002041385-26-000065.md) | Quarterly report, period 2026-07-03 | 0002041385-26-000065 |
| 2026-07-30 | 10:43 ET | [8-K](/filings/0002041385-26-000062.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0002041385-26-000062 |
| 2026-06-10 | 20:11 ET | [8-K](/filings/0002041385-26-000055.md) | 5.07 Shareholder vote results | 0002041385-26-000055 |
| 2026-05-13 | 11:00 ET | [8-K](/filings/0002041385-26-000050.md) | 8.01 Other events | 0002041385-26-000050 |
| 2026-05-12 | 20:05 ET | [10-Q](/filings/0002041385-26-000046.md) | Quarterly report, period 2026-04-03 | 0002041385-26-000046 |
| 2026-05-12 | 11:18 ET | [8-K](/filings/0002041385-26-000043.md) | 2.02 Results of operations | 0002041385-26-000043 |
| 2026-04-23 | 12:01 ET | [DEF 14A](/filings/0002041385-26-000035.md) | Proxy statement, period 2026-06-05 | 0002041385-26-000035 |
| 2026-03-31 | 21:09 ET | [8-K](/filings/0001185185-26-001195.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001185185-26-001195 |
| 2026-02-26 | 21:21 ET | [10-K](/filings/0002041385-26-000023.md) | Annual report, period 2025-12-31 | 0002041385-26-000023 |
| 2026-02-17 | 11:05 ET | [8-K](/filings/0002041385-26-000020.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0002041385-26-000020 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0002041385-26-000023.md), filed Feb 26, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 2041385
- Tickers: RAL
- Exchange: NYSE
- SIC code: 3823 Industrial Instruments For Measurement, Display, and Control
- State of incorporation: DE
- Filer category: Non-accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.